Related Experiment Videos

The complexity of bladder cancer: long noncoding RNAs are on the stage

Quanan Zhang1, Mo Su, Guangming Lu

  • 1Department of Pathology, Laboratory of Molecular Pathology and Molecular Imaging, Jinling Hospital, School of Medicine Nanjing University, 305 Zhong Shan Dong Lu, 210002 Nanjing, China. wangjd@aliyun.com.

Molecular Cancer
|September 7, 2013
PubMed

Insights

Long noncoding RNAs (lncRNAs) are crucial regulators of cell function and development. This study explores their role in bladder cancer, focusing on oncogenic lncRNAs for diagnosis and targeted therapy.

Area of Science:

  • Genomics
  • Molecular Biology
  • Cancer Research

Background:

  • Long noncoding RNAs (lncRNAs) are key regulators of cellular processes.
  • Dysregulated lncRNAs are implicated in various cancers, including bladder cancer.
  • lncRNAs function through diverse mechanisms, including chromatin modification and gene regulation.

Purpose of the Study:

  • To review the latest advancements in lncRNA biology.
  • To discuss oncogenic lncRNAs in bladder cancer core pathways.
  • To explore the diagnostic and therapeutic applications of lncRNAs in bladder cancer.

Main Methods:

  • Literature review of lncRNA biology and function.
  • Analysis of lncRNA involvement in bladder cancer pathways.
  • Discussion of lncRNA-based diagnostic and therapeutic strategies.

Main Results:

  • lncRNAs play significant roles in regulating gene transcription.
  • Specific oncogenic lncRNAs are involved in critical pathways of bladder cancer.
  • lncRNAs show potential as biomarkers for bladder cancer diagnosis and targeted treatment.

Conclusions:

  • lncRNAs are integral to the complex gene regulatory networks in bladder cancer.
  • Understanding lncRNA functions can lead to novel diagnostic and therapeutic approaches.
  • lncRNAs represent a promising frontier in bladder cancer research and clinical application.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA (lncRNA)...
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...